HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Fujiwara Selected Research

cetraxate

2/2007Are gastroprotective drugs useful for gastric ulcer healing: re-evaluation using current ICH E9 guidelines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Fujiwara Research Topics

Disease

37Neoplasms (Cancer)
01/2021 - 01/2000
12Neoplasm Micrometastasis
10/2001 - 03/2000
11Breast Neoplasms (Breast Cancer)
01/2017 - 05/2000
9Carcinoma (Carcinomatosis)
12/2016 - 04/2000
9Ulcer
02/2007 - 01/2000
8Stomach Neoplasms (Stomach Cancer)
05/2008 - 01/2000
8Esophageal Neoplasms (Esophageal Cancer)
01/2008 - 01/2000
8Stomach Ulcer (Gastric Ulcer)
02/2007 - 01/2000
7Neoplasm Metastasis (Metastasis)
01/2016 - 12/2000
6Lung Neoplasms (Lung Cancer)
02/2011 - 04/2000
6Colorectal Neoplasms (Colorectal Cancer)
10/2010 - 02/2000
6Infections
08/2009 - 01/2000
6Gastroesophageal Reflux (GERD)
07/2007 - 01/2000
5Body Weight (Weight, Body)
01/2018 - 01/2000
5Lymphatic Metastasis
01/2016 - 01/2001
5Carcinogenesis
12/2001 - 03/2000
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2001 - 01/2000
5Hepatocellular Carcinoma (Hepatoma)
03/2001 - 03/2000
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2016 - 02/2001
4Disease Progression
12/2016 - 06/2001
4Type 2 Diabetes Mellitus (MODY)
06/2016 - 04/2000
4Cicatrix (Scar)
06/2012 - 06/2001
4Colonic Neoplasms (Colon Cancer)
07/2004 - 03/2000
4Melanoma (Melanoma, Malignant)
08/2001 - 04/2000
3Frailty
01/2021 - 01/2017
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 03/2000
3Heartburn (Pyrosis)
04/2016 - 08/2003
3Esophageal Squamous Cell Carcinoma
02/2012 - 01/2000
3Necrosis
02/2008 - 06/2001
3Hemorrhage
11/2007 - 04/2000
3Hyperplasia
04/2006 - 12/2001
3Adenocarcinoma
09/2001 - 03/2000
2Deglutition Disorders (Dysphagia)
10/2017 - 06/2012
2Pathologic Complete Response
08/2016 - 07/2010
2Eosinophilia
05/2015 - 04/2015
2Pathologic Constriction (Stenosis)
06/2012 - 02/2001
2Inflammation (Inflammations)
05/2008 - 01/2001
2Dyspepsia (Indigestion)
01/2004 - 01/2002
2Gastritis
01/2004 - 07/2003
2Schizophrenia (Dementia Praecox)
01/2002 - 08/2000
2Peptic Esophagitis (Reflux Esophagitis)
12/2001 - 01/2000
2Pneumoperitoneum
10/2001 - 01/2000

Drug/Important Bio-Agent (IBA)

14Messenger RNA (mRNA)IBA
12/2001 - 01/2000
9AcidsIBA
07/2007 - 06/2001
7Carcinoembryonic AntigenIBA
01/2016 - 02/2000
7Proteins (Proteins, Gene)FDA Link
05/2008 - 01/2000
6Proton Pump InhibitorsIBA
04/2016 - 01/2003
6Pharmaceutical PreparationsIBA
10/2010 - 01/2000
6RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2001 - 03/2000
4Indicators and Reagents (Reagents)IBA
01/2022 - 04/2000
4CytokinesIBA
05/2008 - 01/2001
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2008 - 01/2000
3Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2009
3Carboplatin (JM8)FDA LinkGeneric
12/2016 - 04/2000
3Trastuzumab (Herceptin)FDA Link
06/2011 - 11/2009
3Famotidine (Pepcid)FDA LinkGeneric
12/2006 - 01/2005
3Phosphotransferases (Kinase)IBA
07/2004 - 04/2001
3Peroxidase (Myeloperoxidase)IBA
07/2003 - 01/2000
3Mammaglobin BIBA
06/2000 - 03/2000
2Biological ProductsIBA
01/2022 - 01/2008
2Serum AlbuminIBA
01/2022 - 01/2018
2GemcitabineFDA Link
01/2021 - 04/2017
2Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 12/2000
2Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 01/2009
2Docetaxel (Taxotere)FDA Link
12/2016 - 07/2001
2Mitomycin (Mitomycin-C)FDA LinkGeneric
06/2012 - 08/2001
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2012 - 07/2004
2AnticoagulantsIBA
10/2010 - 11/2000
2SteroidsIBA
08/2009 - 02/2001
2Rabeprazole (Aciphex)FDA Link
05/2008 - 07/2007
2LigandsIBA
02/2008 - 09/2001
2Anti-Bacterial Agents (Antibiotics)IBA
02/2008 - 01/2003
2Therapeutic UsesIBA
01/2008 - 03/2001
2N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
06/2007 - 07/2004
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2006 - 04/2000
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2004 - 01/2000
2Clarithromycin (Biaxin)FDA LinkGeneric
01/2003 - 10/2001
2heparanaseIBA
12/2001 - 10/2001
2EnzymesIBA
10/2001 - 04/2000
2Genetic Markers (Genetic Marker)IBA
08/2001 - 05/2001
2Cell-Free Nucleic AcidsIBA
08/2001 - 04/2000
2Green Fluorescent ProteinsIBA
07/2001 - 05/2000
2enhanced green fluorescent proteinIBA
07/2001 - 05/2000
2Cell Adhesion MoleculesIBA
06/2001 - 05/2000
2Estrogen ReceptorsIBA
05/2001 - 11/2000
2Keratin-20 (Cytokeratin 20)IBA
05/2001 - 07/2000

Therapy/Procedure

21Therapeutics
06/2017 - 01/2000
14Drug Therapy (Chemotherapy)
01/2021 - 12/2000
8Lymph Node Excision (Lymph Node Dissection)
05/2015 - 01/2001
7Neoadjuvant Therapy
01/2021 - 05/2008
5Radiotherapy
04/2017 - 12/2000
5Gastrectomy
05/2008 - 01/2000
5Esophagectomy
01/2008 - 01/2000
4Ligation
04/2002 - 01/2000
3Aftercare (After-Treatment)
01/2008 - 03/2001
3Hepatectomy
03/2001 - 04/2000
2Intraperitoneal Injections
01/2008 - 01/2000
2Operative Surgical Procedures
08/2003 - 01/2000
2Surgical Instruments (Clip)
03/2003 - 11/2002
2Anesthesia
12/2001 - 01/2000